Educate Hep C Patients About Potential Glucose Effects of Antivirals
April 2020
Health Canada is warning about possible blood glucose changes in patients who take certain hep C meds.
The concern is with newer "direct-acting antivirals"...such as Zepatier, Maviret, and Epclusa.
There are reports of these meds linked to low or high blood glucose levels and new-onset diabetes.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive